Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals Market Cap

Arrowhead Pharmaceuticals has a market cap or net worth of $9.25 billion as of April 13, 2026. Its market cap has increased by 426.88% in one year.

• Market Cap: 9.25B
• Enterprise Value: 8.91B
• 1-Year Change: 426.88%
• Ranking: #972
• Category: Mid-Cap
• Stock Price: $66.09

Market Cap Chart

Since January 15, 2004, Arrowhead Pharmaceuticals's market cap has increased from $300.00K to $9.25B, an increase of 3,084,809.15%. That is a compound annual growth rate of 59.14%.

Market Cap History

Date	Market Cap	% Change
Apr 10, 2026	9.12B	1.17%
Dec 31, 2025	9.02B	285.42%
Dec 31, 2024	2.34B	-28.84%
Dec 29, 2023	3.29B	-23.54%
Dec 30, 2022	4.30B	-37.84%
Dec 31, 2021	6.92B	-11.95%
Dec 31, 2020	7.86B	29.67%
Dec 31, 2019	6.06B	451.13%
Dec 31, 2018	1.10B	299.42%
Dec 29, 2017	275.20M	154.58%
Dec 30, 2016	108.10M	-70.48%
Dec 31, 2015	366.20M	-9.27%
Dec 31, 2014	403.60M	-3.88%
Dec 31, 2013	419.90M	1,153.43%
Dec 31, 2012	33.50M	-24.04%
Dec 30, 2011	44.10M	-31.42%
Dec 31, 2010	64.30M	93.09%
Dec 31, 2009	33.30M	-15.70%
Dec 31, 2008	39.50M	-72.93%
Dec 31, 2007	145.90M	-2.60%
Dec 29, 2006	149.80M	25.99%
Dec 30, 2005	118.90M	101.87%
Dec 31, 2004	58.90M	19,533.33%
Jan 15, 2004	300.00K	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
BioMarin Pharmaceutical	10.49B
ABIVAX Société Anonyme	10.03B
Axsome Therapeutics	9.11B
Praxis Precision Medicines	8.80B
Vaxcyte	8.76B
Bio-Techne	8.69B
Nuvalent	8.08B
Halozyme Therapeutics	8.03B